Evaluation of Immature Platelet Fraction (IPF) in respiratory tract infections.
V. Georgakopoulou (Athens, Greece), K. Mantzouranis (Athens, Greece), D. Mermigkis (Athens, Greece), D. Melemeni (Athens, Greece), G. Petsinis (Athens, Greece), E. Karakou (Athens, Greece), A. Lekkakou (Athens, Greece), N. Trakas (Athens, Greece), R. Chatzikyriakou (Athens, Greece), X. Tsiafaki (Athens, Greece)
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Georgakopoulou (Athens, Greece), K. Mantzouranis (Athens, Greece), D. Mermigkis (Athens, Greece), D. Melemeni (Athens, Greece), G. Petsinis (Athens, Greece), E. Karakou (Athens, Greece), A. Lekkakou (Athens, Greece), N. Trakas (Athens, Greece), R. Chatzikyriakou (Athens, Greece), X. Tsiafaki (Athens, Greece). Evaluation of Immature Platelet Fraction (IPF) in respiratory tract infections.. 2351
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: